Prostate Artery Embolization in Patients above Eighty Years Old: Clinical Efficacy and Safety

Prostate Artery Embolization in Patients above Eighty Years Old: Clinical Efficacy and Safety

Objectives Prostate artery embolization (PAE) has been established as an effective treatment option for benign prostate hyperplasia or hematuria of prostatic origin. We aim to confirm the effectiveness and safety of PAE in elderly patients aged ≥ 80 years old. Materials and Methods Betwee...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hossam Saro, M. Th. Solyman, Mohammed Zaki, M.A. N. Hasan, N. Thulasidasan, Sharon Clovis, Oussama Elhage, Rick Popert, Tarun Sabharwal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-07-01
Series:	The Arab Journal of Interventional Radiology
Subjects:	benign prostate hyperplasia urinary retention prostate-induced hematuria prostate artery embolization lower urinary tract symptoms
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1748758
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Endovascular Management in a Case of Recurrent Bleed Following Transurethral Resection of the Prostate
by: R. B. Nerli, et al.
Published: (2018-01-01)

Prostatic Artery Embolization for Benign Prostatic Hyperplasia—A Primer for Interventional Radiologists
by: Tiago Bilhim, et al.
Published: (2021-07-01)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)

Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study
by: Jules Pouchot, et al.
Published: (2024-12-01)

Early experience of prostate artery embolization: a retrospective single-centre study
by: Emir Majbar, et al.
Published: (2025-01-01)

Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization
by: Issam Kably, et al.
Published: (2020-07-01)

Prostatic Artery Embolization through the Profunda Femoris Artery
by: Abin Sajan, et al.
Published: (2021-01-01)

Benign Prostatic Hyperplasia Treated Entirely by Unilateral Prostate Artery Embolization
by: Mohamed Shaker, et al.
Published: (2020-01-01)

Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts
by: Cheng-Ling Lee, et al.
Published: (2017-01-01)

Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01)

Possibilities of Therapeutic and Prophylactic Tactics in Management of Benign Prostatic Hyperplasia in Tuberculosis Patients
by: Z. R. Rashidov, et al.
Published: (2021-08-01)

Thermo-expandable intraprostatic nitinol stents in the treatment of bladder outlet obstruction: a consecutive case series
by: Albert Arch, et al.
Published: (2024-10-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)

OPTIMIZATION OF TREATMENT AND PROGNOSTIC APPROACHES TO BENIGN PROSTATIC HYPERPLASIA COMPLICATIONS
by: S. M. Pikalov, et al.
Published: (2020-11-01)

Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes
by: Joao G. Porto, et al.
Published: (2024-03-01)

Features and Management of Incidental Prostatic Lymphoma Obtained in Lower Urinary Tract Symptoms Surgery: A Systematic Review
by: Jeremy Cheng, et al.
Published: (2025-04-01)

Efficacy of Holmium Laser Enucleation of the Prostate in Patients With Detrusor Underactivity or Acontractile Bladder
by: Seongik Choi, et al.
Published: (2025-06-01)

Analyzing the quality and validity of holmium laser enucleation of prostate (HoLEP) videos on social media
by: Emrullah Sogutdelen, et al.
Published: (2021-07-01)

Antibiotic resistance of microorganisms isolated from the urine of patients before surgical treatment for benign prostatic hyperplasia: results from a 7-year single-center study
by: M. I. Kogan, et al.
Published: (2024-04-01)

Management of Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia During and After COVID-19
by: Dean Elterman, et al.
Published: (2021-11-01)

Non-target embolization of the glans penis during prostatic artery embolization
by: Cameron James Parkin, et al.
Published: (2021-09-01)

Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
by: Taofiq Olayinka Mohammed, et al.
Published: (2024-12-01)

National Trends in Medication Prescriptions for Male Lower Urinary Tract Symptoms and Erectile Dysfunction: Findings from the Norwegian Prescription Database
by: Patrick Juliebø-Jones, et al.
Published: (2025-05-01)

Clinical portrait of an "ordinary" patient with benign prostatic hyperplasia and the efficacy of treating lower urinary tract symptoms
by: V. L. Medvedev, et al.
Published: (2023-04-01)

Bladder drainage methods for acute urinary retention due to benign prostatic hyperplasia: patient-preference analysis
by: A. I. Volnukhin, et al.
Published: (2024-09-01)

Comparison of 120 W 2-µm laser resection of the prostate outcomes in patients with or without preoperative urinary retention
by: Xiaolong Liu, et al.
Published: (2016-11-01)

CORRELATION OF STORAGE SYMPTOMS OR OVERACTIVE BLADDER SYMPTOMS POST TRANSURETHRAL RESECTION OF THE PROSTATE WITH THE DURATION OF CATHETER USE IN A PATIENT WITH URINARY RETENTION DUE TO BENIGN PROSTATE HYPERPLASIA
by: Alfindy Perdinan, et al.
Published: (2025-05-01)

SGLT2 Inhibitors in Patients with Urogenital Malformations and Urinary Diversions: Risks, Benefits, and Clinical Considerations
by: Mohammed Abdulrasak, et al.
Published: (2025-05-01)

Constitutional approach in studying human diseases at the present stage
by: N. Yu. Klimov, et al.
Published: (2018-12-01)

Smooth muscle contractility of laser-enucleated prostate tissues and impacts of preoperative α1-blocker treatment in patients with and without catheterization
by: Patrick Keller, et al.
Published: (2025-02-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

Type II diabetes miletus: Does it increase the chance to fail the first trail of void following transurethral resection of prostate (TURP)?
by: Abdullah Alkhayal, et al.
Published: (2025-04-01)

Long-term follow-up of “three horse shoe-like incision (3-HSI) holmium laser enucleation of the prostate: outcomes and efficacy of a novel en-bloc technique for anatomic transurethral prostatectomy”
by: Maximilian Glienke, et al.
Published: (2025-07-01)

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
by: Chenye Tang, et al.
Published: (2025-06-01)

Prevalence of benign prostatic hyperplasia and prostrate cancer among suburban residents in Southern Nigeria
by: Ugochukwu Esomonu, et al.
Published: (2024-12-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
by: Yiji Peng, et al.
Published: (2025-03-01)